These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39044524)

  • 21. The dual amylin and calcitonin receptor agonist KBP-336 elicits a unique combination of weight loss, antinociception and bone protection - a novel disease-modifying osteoarthritis drug.
    Mohamed KE; Larsen AT; Melander S; Andersen F; Kerrn EB; Karsdal MA; Henriksen K
    Arthritis Res Ther; 2024 Jul; 26(1):129. PubMed ID: 38997785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile.
    Larsen AT; Gydesen S; Sonne N; Karsdal MA; Henriksen K
    BMC Endocr Disord; 2021 Jan; 21(1):10. PubMed ID: 33413317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KBP-042 improves bodyweight and glucose homeostasis with indices of increased insulin sensitivity irrespective of route of administration.
    Hjuler ST; Andreassen KV; Gydesen S; Karsdal MA; Henriksen K
    Eur J Pharmacol; 2015 Sep; 762():229-38. PubMed ID: 26027795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholestyramine reverses hyperglycemia and enhances glucose-stimulated glucagon-like peptide 1 release in Zucker diabetic fatty rats.
    Chen L; McNulty J; Anderson D; Liu Y; Nystrom C; Bullard S; Collins J; Handlon AL; Klein R; Grimes A; Murray D; Brown R; Krull D; Benson B; Kleymenova E; Remlinger K; Young A; Yao X
    J Pharmacol Exp Ther; 2010 Jul; 334(1):164-70. PubMed ID: 20413600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
    Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
    Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fenugreek seed extract ameliorates cognitive deficits in streptozotocin-induced diabetic rats.
    Kodumuri PK; Thomas C; Jetti R; Pandey AK
    J Basic Clin Physiol Pharmacol; 2019 Jul; 30(4):. PubMed ID: 31326961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empagliflozin alleviates diabetes-induced cognitive impairments by lowering nicotinamide adenine dinucleotide phosphate oxidase-4 expression and potentiating the antioxidant defense system in brain tissue of diabetic rats.
    Yaribeygi H; Hemmati MA; Nasimi F; Pakdel R; Jamialahmadi T; Sahebkar A
    Behav Brain Res; 2024 Mar; 460():114830. PubMed ID: 38141785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats.
    Winter CL; Lange JS; Davis MG; Gerwe GS; Downs TR; Peters KG; Kasibhatla B
    Exp Biol Med (Maywood); 2005 Mar; 230(3):207-16. PubMed ID: 15734724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.
    Palleria C; Leo A; Andreozzi F; Citraro R; Iannone M; Spiga R; Sesti G; Constanti A; De Sarro G; Arturi F; Russo E
    Behav Brain Res; 2017 Mar; 321():157-169. PubMed ID: 28062257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ferulic acid attenuates diabetes-induced cognitive impairment in rats via regulation of PTP1B and insulin signaling pathway.
    Wang H; Sun X; Zhang N; Ji Z; Ma Z; Fu Q; Qu R; Ma S
    Physiol Behav; 2017 Dec; 182():93-100. PubMed ID: 28988132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of an Andrographis paniculata extract and andrographolide on cognitive functions in streptozotocin-induced diabetic rats.
    Thakur AK; Rai G; Chatterjee SS; Kumar V
    Pharm Biol; 2016 Sep; 54(9):1528-38. PubMed ID: 26810454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of Prosopis glandulosa as antidiabetic treatment in rat models of diabetes and insulin resistance.
    George C; Lochner A; Huisamen B
    J Ethnopharmacol; 2011 Sep; 137(1):298-304. PubMed ID: 21645608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total saponins from Rhizoma Anemarrhenae ameliorate diabetes-associated cognitive decline in rats: involvement of amyloid-beta decrease in brain.
    Liu YW; Zhu X; Lu Q; Wang JY; Li W; Wei YQ; Yin XX
    J Ethnopharmacol; 2012 Jan; 139(1):194-200. PubMed ID: 22101084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosa canina L. improves learning and memory-associated cognitive impairment by regulating glucose levels and reducing hippocampal insulin resistance in high-fat diet/streptozotocin-induced diabetic rats.
    Ertas B; Hazar-Yavuz AN; Topal F; Keles-Kaya R; Karakus Ö; Ozcan GS; Taskin T; Cam ME
    J Ethnopharmacol; 2023 Sep; 313():116541. PubMed ID: 37088237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic and Cognitive Effects of Ranolazine in Type 2 Diabetes Mellitus: Data from an in vivo Model.
    Cassano V; Leo A; Tallarico M; Nesci V; Cimellaro A; Fiorentino TV; Citraro R; Hribal ML; De Sarro G; Perticone F; Sesti G; Russo E; Sciacqua A
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 32023991
    [No Abstract]   [Full Text] [Related]  

  • 36. TAK-875, a GPR40/FFAR1 agonist, in combination with metformin prevents progression of diabetes and β-cell dysfunction in Zucker diabetic fatty rats.
    Ito R; Tsujihata Y; Matsuda-Nagasumi K; Mori I; Negoro N; Takeuchi K
    Br J Pharmacol; 2013 Oct; 170(3):568-80. PubMed ID: 23848179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cocoa-rich diet ameliorates hepatic insulin resistance by modulating insulin signaling and glucose homeostasis in Zucker diabetic fatty rats.
    Cordero-Herrera I; Martín MÁ; Escrivá F; Álvarez C; Goya L; Ramos S
    J Nutr Biochem; 2015 Jul; 26(7):704-12. PubMed ID: 25814291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dual amylin- and calcitonin-receptor agonist KBP-042 increases insulin sensitivity and induces weight loss in rats with obesity.
    Hjuler ST; Gydesen S; Andreassen KV; Pedersen SL; Hellgren LI; Karsdal MA; Henriksen K
    Obesity (Silver Spring); 2016 Aug; 24(8):1712-22. PubMed ID: 27296301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of S 15511, a therapeutic metabolite of the insulin-sensitizing agent S 15261, in the Zucker Diabetic Fatty rat.
    Pickavance LC; Wilding JP
    Diabetes Obes Metab; 2007 Jan; 9(1):114-20. PubMed ID: 17199726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.